Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Jan;267(1):203-213.
doi: 10.1007/s00415-019-09579-4. Epub 2019 Oct 14.

ATP8A2-related disorders as recessive cerebellar ataxia

Affiliations
Free article
Multicenter Study

ATP8A2-related disorders as recessive cerebellar ataxia

Claire Guissart et al. J Neurol. 2020 Jan.
Free article

Abstract

ATP8A2-related disorders are autosomal recessive conditions that associate encephalopathy with or without hypotonia, psychomotor delay, abnormal movements, chorea, tremor, optic atrophy and cerebellar atrophy (CARMQ4). Through a multi-centric collaboration, we identified six point mutations (one splice site and five missense mutations) involving ATP8A2 in six individuals from five families. Two patients from one family with the homozygous p.Gly585Val mutation had a milder presentation without encephalopathy. Expression and functional studies of the missense mutations demonstrated that protein levels of four of the five missense variants were very low and lacked phosphatidylserine-activated ATPase activity. One variant p.Ile215Leu, however, expressed at normal levels and displayed phospholipid-activated ATPase activity similar to the non-mutated protein. We therefore expand for the first time the phenotype related to ATP8A2 mutations to less severe forms characterized by cerebellar ataxia without encephalopathy and suggest that ATP8A2 should be analyzed for all cases of syndromic or non-syndromic recessive or sporadic ataxia.

Keywords: ATP8A2; Ataxia; CAMRQ; P4-ATPase; Psychomotor delay.

PubMed Disclaimer

References

    1. Cerebellum. 2019 Dec;18(6):1098-1125 - PubMed
    1. BMC Neurosci. 2015 Dec 23;16(1):96 - PubMed
    1. J Biol Chem. 2011 May 13;286(19):17205-16 - PubMed
    1. Mol Neurobiol. 2004 Apr;29(2):197-212 - PubMed
    1. Sci Rep. 2018 Jul 17;8(1):10795 - PubMed

Publication types

Substances

LinkOut - more resources